Home Newsfeeds Raymond James Downgrades Duck Creek Technologies to Market Perform

Raymond James Downgrades Duck Creek Technologies to Market Perform

Raymond James analyst Alexander Sklar downgrades Duck Creek Technologies (NASDAQ:DCT) from Outperform to Market Perform.

byBenzinga Newsdesk

January 17, 2023

1 minute read

Raymond James analyst Alexander Sklar downgrades Duck Creek Technologies (NASDAQ:DCT) from Outperform to Market Perform.

News

Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirement Deficiency

By Benzinga Newsdesk

May 30, 4:53 PM

Collective Audience, Inc. (NASDAQ:CAUD) has received an additional notification from the listing qualifications department of The Nasdaq Stock Market. Similar to the previous notifications announced on April 25, the new

CAUD

Analyst Ratings

Expert Ratings for SilverBow Resources

By Benzinga Insights

October 12, 4:00 PM

SilverBow Resources (NYSE:SBOW) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

SBOW

Extend Life Expectancy Against Aggressive Brain Cancers – Nano-Cap Firm Biodexa’s Investigational Drug Shows Potential

By Vandana Singh

March 28, 12:43 PM

Biodexa Pharmaceuticals' MTX110, revolutionizing brain cancer treatment with innovative drug delivery technology. Early trials show promising survival rate extensions in Diffuse Midline Glioma and Recurrent Glioblastoma patients. Learn more about MTX110's potential.

BDRX

Capital Group Aims To Double Assets To $4 Trillion By 2031: Mike Gitlin Says ‘Europe And Asia Are Absolutely Critical To Our Future’

By Benzinga Neuro

June 12, 6:12 AM

Capital Group is looking to expand its fixed-income business, accelerate its international presence, and diversify its core equities franchise. This initiative is aimed at counteracting client withdrawals and competing with faster-growing fund rivals.

CGMS

Raymond James Downgrades Duck Creek Technologies to Market Perform

Related Posts

Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirement Deficiency

Expert Ratings for SilverBow Resources

Extend Life Expectancy Against Aggressive Brain Cancers – Nano-Cap Firm Biodexa’s Investigational Drug Shows Potential

Capital Group Aims To Double Assets To $4 Trillion By 2031: Mike Gitlin Says ‘Europe And Asia Are Absolutely Critical To Our Future’